These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 25959417

  • 1. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.
    Liu J, Campbell C, Nam HK, Caron A, Yadav MC, Millán JL, Hatch NE.
    Bone; 2015 Sep; 78():203-11. PubMed ID: 25959417
    [Abstract] [Full Text] [Related]

  • 2. Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.
    Liu J, Nam HK, Campbell C, Gasque KC, Millán JL, Hatch NE.
    Bone; 2014 Oct; 67():81-94. PubMed ID: 25014884
    [Abstract] [Full Text] [Related]

  • 3. Bone mineralization-dependent craniosynostosis and craniofacial shape abnormalities in the mouse model of infantile hypophosphatasia.
    Durussel J, Liu J, Campbell C, Nam HK, Hatch NE.
    Dev Dyn; 2016 Feb; 245(2):175-82. PubMed ID: 26605996
    [Abstract] [Full Text] [Related]

  • 4. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
    Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman MJ, Millán JL.
    Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339
    [Abstract] [Full Text] [Related]

  • 5. Enzyme replacement prevents enamel defects in hypophosphatasia mice.
    Yadav MC, de Oliveira RC, Foster BL, Fong H, Cory E, Narisawa S, Sah RL, Somerman M, Whyte MP, Millán JL.
    J Bone Miner Res; 2012 Aug; 27(8):1722-34. PubMed ID: 22461224
    [Abstract] [Full Text] [Related]

  • 6. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D10 Improves the Skeletal and Dentoalveolar Phenotypes in Alpl-/- Mice.
    Kinoshita Y, Mohamed FF, Amadeu de Oliveira F, Narisawa S, Miyake K, Foster BL, Millán JL.
    J Bone Miner Res; 2021 Sep; 36(9):1835-1849. PubMed ID: 34076297
    [Abstract] [Full Text] [Related]

  • 7. Conditional Alpl Ablation Phenocopies Dental Defects of Hypophosphatasia.
    Foster BL, Kuss P, Yadav MC, Kolli TN, Narisawa S, Lukashova L, Cory E, Sah RL, Somerman MJ, Millán JL.
    J Dent Res; 2017 Jan; 96(1):81-91. PubMed ID: 27582029
    [Abstract] [Full Text] [Related]

  • 8. Enzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case series.
    Kosnik-Infinger L, Gendron C, Gordon CB, Pan BS, van Aalst JA, Vogel TW.
    Neurosurg Focus; 2015 May; 38(5):E10. PubMed ID: 25929963
    [Abstract] [Full Text] [Related]

  • 9. The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis.
    Wang E, Nam HK, Liu J, Hatch NE.
    Orthod Craniofac Res; 2015 Apr; 18 Suppl 1(0 1):196-206. PubMed ID: 25865549
    [Abstract] [Full Text] [Related]

  • 10. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 11. Tooth root dentin mineralization defects in a mouse model of hypophosphatasia.
    Foster BL, Nagatomo KJ, Tso HW, Tran AB, Nociti FH, Narisawa S, Yadav MC, McKee MD, Millán JI, Somerman MJ.
    J Bone Miner Res; 2013 Feb; 28(2):271-82. PubMed ID: 22991301
    [Abstract] [Full Text] [Related]

  • 12. Visualization of Mineral-Targeted Alkaline Phosphatase Binding to Sites of Calcification In Vivo.
    Amadeu de Oliveira F, Narisawa S, Bottini M, Millán JL.
    J Bone Miner Res; 2020 Sep; 35(9):1765-1771. PubMed ID: 32343017
    [Abstract] [Full Text] [Related]

  • 13. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F.
    Bone; 2019 Oct 10; 127():67-74. PubMed ID: 31152801
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb 10; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 19. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.
    Foster BL, Sheen CR, Hatch NE, Liu J, Cory E, Narisawa S, Kiffer-Moreira T, Sah RL, Whyte MP, Somerman MJ, Millán JL.
    J Dent Res; 2015 May 10; 94(5):706-14. PubMed ID: 25716980
    [Abstract] [Full Text] [Related]

  • 20. Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model.
    Koh AJ, Nam HK, Michalski MN, Do J, McCauley LK, Hatch NE.
    Osteoporos Int; 2022 Nov 10; 33(11):2423-2433. PubMed ID: 35871207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.